BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2014
View Archived Issues
FISSEQ technique developed for spatial resolution of gene expression
Read More
BC-001 shows efficacy in breast and renal cell carcinoma xenograft models
Read More
Bayer Schering Pharma identifies novel benzazepine bromodomain-containing protein 4 inhibitor
Read More
New biomarker identified for neuroblastoma
Read More
Gilead presents promising results from phase III ION-1, ION-2 and ION-3 trials
Read More
Pfizer discloses new EZH2 inhibitors for cancer
Read More
Nitto Denko to advance anti-fibrosis siRNA into phase I/II
Read More
Antibody-drug conjugates including DGN-462 demonstrate anticancer activity
Read More
NICE provides guidance on two treatments for lung cancer
Read More
Chinese researchers disclose new agents for HCV infection
Read More
Biodel and HEC Pharm subsidiary to develop ultra-rapid-acting insulin aspart
Read More
Novel translocator protein PET ligand synthesized for imaging glioma
Read More
Custirsen plus cabazitaxel/prednisone obtains FDA fast track designation
Read More
FDA approves siltuximab for multicentric Castleman's disease
Read More
Researchers at Bayer Schering Pharma present new agents for hyperproliferative disorders
Read More
Valeant proposes merger with Allergan
Read More
FDA clears study of ProHema in pediatric patients
Read More
Novel DPP IV inhibitors disclosed by Qilu Pharmaceutical
Read More
Avalanche Biotechnologies secures funding to advance retinal disorder pipeline
Read More
Courtagen to genetically profile patients at Connecticut Children's Autism Neurogenetics Clinic
Read More
Synthetic Biologics reports preclinical data for novel pertussis therapeutic
Read More
Lupin and Yoshindo to create joint venture
Read More
AveXis closes financing round to advance its SMA gene therapy program
Read More
Roche recaps progress of first quarter 2014
Read More
FDA awards orphan drug designation to Tolero's alvocidib for AML
Read More